Raia Drogasil
R$19.50Change from previous close: +4.00%Absolute change: +R$0.75
At a glance
- Revenue growth
- +13.84%
- 2025 vs 2024
- Net income growth
- +8.08%
- 2025 vs 2024
- Net margin
- 2.9%
- 2024: 3.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 11,062 | 10,569 | 12,103 | — | 10,075 | 9,273 |
| Cost of revenue | 7,365 | 7,174 | 8,539 | — | 6,939 | 6,451 |
| Gross profit | 3,698 | 3,394 | 3,565 | — | 3,136 | 2,822 |
| Selling, general and administrative | 2,853 | 2,745 | 2,817 | — | 2,438 | 2,367 |
| Operating income | 836 | 652 | 569 | — | 697 | 517 |
| EBIT | 809 | 425 | 602 | — | 647 | 388 |
| EBITDA | 1,337 | 988 | 602 | 1,331 | 1,151 | 885 |
| Interest expense | 278 | 299 | 299 | — | 270 | 222 |
| Pre-tax income | 530 | 127 | 303 | — | 377 | 165 |
| Income tax | 114 | -20.5 | 12.6 | — | 52.7 | 23.2 |
| Net income | 425 | 159 | 305 | — | 374 | 164 |
| Net income to common shareholders | 425 | 159 | 305 | — | 374 | 164 |
| Basic EPS | 0.26 | 0.10 | — | 0.27 | 0.22 | 0.10 |
| Diluted EPS | 0.25 | 0.09 | — | 0.27 | 0.22 | 0.10 |
| Average shares (basic) | 1,648 | 1,647 | — | 1,680 | 1,680 | 1,679 |
| Average shares (diluted) | 1,676 | 1,693 | — | 1,694 | 1,689 | 1,687 |